Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 135,089 | 105,419 | 315 | 0 | N/A |
| Marketable Securities | 266,740 | 123,439 | N/A | 0 | N/A |
| TOTAL | $409,317 | $231,953 | $445 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 5,425 | 3,193 | N/A | 0 | N/A |
| Other Non-Current Assets | 11,862 | 4,273 | 0 | 0 | 0 |
| TOTAL | $17,287 | $7,466 | $N/A | $N/A | $N/A |
| Total Assets | $426,604 | $239,419 | $445 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 956 | 2,182 | 97 | 0 | 0 |
| Accrued Expenses | 35,967 | 18,221 | 1,169 | 0 | N/A |
| TOTAL | $36,923 | $20,403 | $1,266 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,459 | N/A | 40 | 0 | N/A |
| Other Non-Current Liabilities | 8,737 | 339,085 | 6,001 | 0 | 0 |
| TOTAL | $37,196 | $339,085 | $6,041 | $N/A | $N/A |
| Total Liabilities | $74,119 | $359,488 | $7,307 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,337 | N/A | N/A | N/A | N/A |
| Common Shares | 7 | 2 | N/A | 0 | N/A |
| Retained earnings | -334,170 | -153,863 | -6,894 | 0 | N/A |
| Other shareholders' equity | 258 | -61 | 0 | 0 | 0 |
| TOTAL | $352,485 | $-120,069 | $-6,862 | $0 | $N/A |
| Total Liabilities And Equity | $426,604 | $239,419 | $445 | $0 | $0 |